𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate-specific antigen — a true progress in diagnosis and follow-up of prostate cancer

✍ Scribed by E. P. Allhoff; C. A. Olsson


Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
74 KB
Volume
11
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prostate-specific antigen in screening o
✍ Dr. T. Ming Chu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

An algorithm for prostate cancer detecti
✍ M. C. Benson; D. J. McMahon; W. H. Cooner; C. A. Olsson 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 818 KB

Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CAP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequen

Prostate-specific antigen and prostate v
✍ Dr. Douglas C. Aziz; Raj B. Barathur 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

## Abstract __Objective:__ To establish the value of serum prostate‐specific antigen (PSA) and prostatespecific antigen per unit volume of prostate gland (PSAD) in detecting prostate carcinoma (CaP) in a hypothetical screening algorithm, a meta‐analysis of the sensitivities, specificities, predicti

Progress in active specific immunotherap
✍ Benjamin A. Tjoa; Gerald P. Murphy 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Treatments available for metastatic prostate cancer have failed to demonstrate significant curative potential. Current efforts are now directed towards developments of novel strategies for the treatment of metastatic prostate cancer. Cancer immunotherapeutic strategies utilize patient immune system